Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0000950170-24-029614

Chief Operating Officer sold 1,591 shares at $25.85 ($41,127)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
HIGH SUSANNA GATTI Chief Operating Officer 2024-03-07 Sale 10b5-1 −1,591 $25.85 $41,127 186,291 D
Open-market sales · 1,591 sh · avg $25.85 · $41,127
Loading xslF345X05/ownership.xml…